Off-the-shelf human stem cell therapy
Naturally Pluripotent Amniotic Fluid Stem Cells
Leveraging 10+ years of authoritative research
Founder, Dr. Bruce K. Young's research at NYU has opened a pathway to the development of regenerative medicineTurning a waste product into stem cells
With a patented process to collect cells, process them, and package them frozen within 48 hours for direct clinical useA stem cell therapy platform
Unlocking the power of cell therapy for a wide variety of indications at scaleNo genetic modification required
Our cells can treat any patient, with no laboratory work neccessary, significantly lowering risks to the patient, and significantly reducing costsNow our team is commercializing this research into a product
Meet Our Team
Dr. Joaquim TriasExecutive Chairman
Veteran biotech founder with 7 exits, including 4 Nasdaq IPOs and 3 acquisitions to Johnson & Johnson and Pfizer. He has extensive experience in discovery and development of several drugs in clinical development. He has extensively published on antibiotic resistance, and has multiple patents on antibiotic discovery. He holds a Ph.D. from the University of Barcelona, Spain, and did a postdoctoral stage at the University of California, Berkeley.
Dr. Bruce K. YoungFounder & CEO
Formerly a Professor of Obstetrics and Gynecology at NYU Grossman School of Medicine. Dr. Young developed the technology and has published scientific reports on stem cell biology in peer-reviewed journals. He is internationally known as a scientific and clinical innovator as well as a leader in Obstetrics and Gynecology. He will design and supervise the clinical trials for FDA approval of the product.
Dr. James CooperChief Science Officer
Professor of Medicine, Assistant Dean of Georgetown University School of Medicine with over 20 years experience in clinical research with numerous scientific presentations and publications. Founder and Chairman of Theragnostic Health, with successful exit.
Dr. Peter WeinsteinChief Counsel
Leading intellectual property, transaction, and corporate law. He received his Juris Doctorate degree at Boston College Law School, and his Ph.D. in Biology with an emphasis in Immunology from the University of Pennsylvania. Dr. Weinstein is a registered patent attorney and is licensed to practice law in California and is admitted to the U.S. District Court for the Central and Southern Districts of California.
Caroline EinauglerCo-Founder
Associate Professor at Rutgers Law School with 15 years of practical experience in information science in both the medical and legal fields. She is an experienced business leader and a founder and marketing SVP of profitable start-up Jurisearch. She has hired, built and directed many high performing teams in successful business areas.
Tom SharonCo-Founder
Silicon Valley technology executive who has founded and led Y Combinator, Softbank, and Sequoia backed startups. Formerly a Product Manager at Google. Leading operations for Amnicell.